M
Marco Canepa
Researcher at University of Genoa
Publications - 153
Citations - 3049
Marco Canepa is an academic researcher from University of Genoa. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 26, co-authored 110 publications receiving 2060 citations. Previous affiliations of Marco Canepa include Johns Hopkins University & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Impact of central obesity on the estimation of carotid-femoral pulse wave velocity.
Marco Canepa,Marco Canepa,Majd AlGhatrif,Gabriele Pestelli,Rohan Kankaria,Sokratis Makrogiannis,James B. Strait,Claudio Brunelli,Edward G. Lakatta,Luigi Ferrucci +9 more
TL;DR: When TD is measured over the body surface, the role of obesity on PWV is substantially overestimated, and after accounting for this bias, PWV was still independently associated with visceral fat but not with other measures of adiposity, confirming its contribution to arterial stiffening.
Journal ArticleDOI
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry.
Marco Canepa,Carlo Fumagalli,Giacomo Tini,Justin Vincent-Tompkins,Sharlene M. Day,Euan A. Ashley,Francesco Mazzarotto,James S. Ware,Michelle Michels,Daniel Jacoby,Carolyn Y. Ho,Iacopo Olivotto +11 more
TL;DR: Evolving HCM populations include progressively greater representation of older patients with sporadic disease, mild phenotypes, and genotype-negative status, which suggests a prominent role of imaging over genetic testing in promoting HCM diagnoses and urges efforts to understand genotypes-negative disease eluding the classic monogenic paradigm.
Journal ArticleDOI
5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1.
Paola Altieri,Roberto Murialdo,Chiara Barisione,Edoardo Lazzarini,Silvano Garibaldi,Patrizia Fabbi,Clarissa Ruggeri,Silvia Borile,Federico Carbone,Andrea Armirotti,Marco Canepa,Alberto Ballestrero,Claudio Brunelli,Fabrizio Montecucco,Pietro Ameri,Paolo Spallarossa +15 more
TL;DR: The effect of 5FU on endothelial senescence and whether GLP‐1 antagonizes it is studied and it is shown that 5.5‐fluorouracil and its prodrug, capecitabine, can damage endothelial cells, whilst endothelial integrity is preserved by glucagon‐like peptide 1.
Journal ArticleDOI
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials.
Stefano Benenati,Mattia Galli,Vincenzo De Marzo,Fabio Pescetelli,Matteo Toma,Felicita Andreotti,Roberta Della Bona,Marco Canepa,Pietro Ameri,Filippo Crea,Italo Porto +10 more
TL;DR: Very short DAPT did not increase the odds of ischemic complications, while reducing thedds of major or any bleeding by over 30%, and subgroup analyses showed consistent results for 1 versus 3 month DAPt and for aspirin versus P2Y12 inhibitor monotherapy following very short D APT.
Journal ArticleDOI
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation.
Francesco Cappelli,Giacomo Tini,Domitilla Russo,Michele Emdin,Annamaria Del Franco,Giuseppe Vergaro,Gianluca Di Bella,Anna Mazzeo,Marco Canepa,Massimo Volpe,Federico Perfetto,Camillo Autore,Carlo Di Mario,Claudio Rapezzi,Maria Beatrice Musumeci +14 more
TL;DR: Prevalence and incidence rate of AEs was high in a large, multicentric, real-world cohort of cardiac amyloidosis, and a consistent proportion of events occurred despite anticoagulation therapy or in patients in sinus rhythm.